Brind.

Veracyte and Transmedics operate within the same molecular diagnostic industry.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Veracyte and Transmedics operate within the same molecular diagnostic industry.

Who's involved

What this event is mainly about
Veracyte (United States)Transmedics

How it developed

Newest first. Tap a step to see who reported it.
  1. The removal of Triumph Group impacted market sentiment on July 26, 2025, affecting companies like Veracyte.Sub-event
  2. The two companies share the molecular diagnostic industry.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksVeracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock? Veracyte VCYT shares rallied 7% in the last trading session to close at $25.25. This move can be attributable to notable volume with a